Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.
about
Amyloid imaging for dementia in CanadaDiagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.Small-molecule PET Tracers for Imaging Proteinopathies.
P2860
Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Canadian Consensus Guidelines ...... on Amyloid imaging in Canada.
@en
type
label
Canadian Consensus Guidelines ...... on Amyloid imaging in Canada.
@en
prefLabel
Canadian Consensus Guidelines ...... on Amyloid imaging in Canada.
@en
P2093
P2860
P356
P1476
Canadian Consensus Guidelines ...... on Amyloid imaging in Canada.
@en
P2093
Bruno Dubois
Jean-Paul Soucy
Robert Laforce
S Gauthier
P2860
P304
P356
10.1017/CJN.2015.401
P577
2016-02-26T00:00:00Z